These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8896666)

  • 21. Calculation of trough-to-peak ratio in the research unit setting. Advantages and disadvantages.
    Elliott HL; Meredith PA
    Am J Hypertens; 1996 Oct; 9(10 Pt 2):71S-75S; discussion 87S-90S. PubMed ID: 8896667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration.
    Meredith PA; Elliott HL
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S26-30. PubMed ID: 7609502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring?
    Neutel JM; Smith DH; Weber MA
    Blood Press Monit; 1999; 4 Suppl 2():S23-8. PubMed ID: 10822419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How important is 24-hour control of blood pressure?
    Morgan T; Anderson A
    Drug Saf; 1996 Oct; 15(4):243-8. PubMed ID: 8905249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trough:peak ratio of the blood pressure response to beta-blockers.
    Wing LM
    J Hypertens Suppl; 1994 Nov; 12(8):S85-90. PubMed ID: 7707162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to evaluate the duration of blood pressure control: the trough:peak ratio and 24-hour monitoring.
    Meredith PA
    J Cardiovasc Pharmacol; 1998; 31 Suppl 2():S17-21. PubMed ID: 9605597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentration-effect analysis of antihypertensive drug response. Focus on calcium antagonists.
    Donnelly R; Elliott HL; Meredith PA
    Clin Pharmacokinet; 1994 Jun; 26(6):472-85. PubMed ID: 8070220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of the trough-to-peak ratio to the 24 h blood pressure load.
    White WB
    Am J Hypertens; 1996 Oct; 9(10 Pt 2):91S-96S; discussion 108S-109S. PubMed ID: 8896670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-response studies with benazepril in mild to moderate hypertension.
    Gomez HJ
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV22-7; discussion IV51-5. PubMed ID: 1893638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure variability: clinical implications and effects of antihypertensive treatment.
    Parati G; Ravogli A; Frattola A; Groppelli A; Ulian L; Santucciu C; Mancia G
    J Hypertens Suppl; 1994 Jul; 12(5):S35-40. PubMed ID: 7965285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Trough-peak ratio and the smoothness index in the assessment of duration and homogeneity of 24-hour antihypertensive effect].
    Parati G; Omboni S; Mancia G
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):345-8. PubMed ID: 12497932
    [No Abstract]   [Full Text] [Related]  

  • 32. [Our point of view. Trough to peak ratio of antihypertensive drugs: methodologic issues and clinical implications].
    Polónia J
    Rev Port Cardiol; 1996 Apr; 15(4):281-92. PubMed ID: 8814671
    [No Abstract]   [Full Text] [Related]  

  • 33. Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension.
    Goldberg MR; Rockhold FW; Offen WW; Dornseif BE
    Clin Pharmacol Ther; 1989 Aug; 46(2):208-18. PubMed ID: 2758730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of trough:peak ratio in the assessment of antihypertensive drug therapy.
    Myers MG
    Can J Cardiol; 1994 Nov; 10 Suppl D():17D-20D. PubMed ID: 7954034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate.
    Mallion JM; Siché JP; Baguet JP; Noirclerc M; De Gaudemaris R
    Blood Press Monit; 1998 Jun; 3(3):189-194. PubMed ID: 10212353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How relevant is the trough-to peak ratio?].
    Ferrari P
    Schweiz Med Wochenschr; 2000 Mar; 130(9):329-35. PubMed ID: 10746273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Felodipine pharmacokinetics and plasma concentration vs effect relationships.
    Blychert E
    Blood Press Suppl; 1992; 2():1-30. PubMed ID: 1343111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents.
    Zanchetti A
    J Hypertens Suppl; 1997 Dec; 15(7):S21-5. PubMed ID: 9532517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical implications of trough to peak ratio].
    Hasebe N; Kikuchi K
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():224-7. PubMed ID: 11028328
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of the effectiveness of antihypertensive therapy. Is the trough-peak ratio the determining factor?].
    Widimský J
    Vnitr Lek; 1996 Feb; 42(2):102-5. PubMed ID: 8686181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.